These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22995027)

  • 21. Images in cardiology. Pacemaker induced torsades de pointes tachycardia.
    Böhm A; Pintér A; Préda I
    Heart; 1998 Nov; 80(5):466. PubMed ID: 9930045
    [No Abstract]   [Full Text] [Related]  

  • 22. Torsade de pointes--a rare presentation of primary hyperaldosteronism.
    Kornelius E; Chen KS; Yang YS; Huang CN
    Am J Emerg Med; 2012 Jan; 30(1):257.e5-7. PubMed ID: 21159461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reproducible induction of EADs and torsade de pointes.
    Pelleg A; Hurt CM; Xu J
    Circulation; 1995 Sep; 92(6):1666-7. PubMed ID: 7664455
    [No Abstract]   [Full Text] [Related]  

  • 24. Torsades de pointes and prolonged QT syndrome in Takotsubo cardiomyopathy.
    Pacha O; Kadikoy H; Amro M; Haque W; Abdellatif A
    J Cardiovasc Med (Hagerstown); 2012 Aug; 13(8):536-40. PubMed ID: 20075742
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug-induced long QT and torsade de pointes: recent advances.
    Kannankeril PJ; Roden DM
    Curr Opin Cardiol; 2007 Jan; 22(1):39-43. PubMed ID: 17143043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Torsade de pointes: the clinical considerations.
    Gowda RM; Khan IA; Wilbur SL; Vasavada BC; Sacchi TJ
    Int J Cardiol; 2004 Jul; 96(1):1-6. PubMed ID: 15203254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Torsade de pointes in a patient with severe aortic stenosis.
    Foo NP; Chen CM; Guo HR; Lin HJ
    Resuscitation; 2006 Jul; 70(1):4-5. PubMed ID: 16757087
    [No Abstract]   [Full Text] [Related]  

  • 28. [Torsade de pointes during anti-arrhythmia treatment with amiodarone].
    Schlienger RG; Haefeli WE; Lüscher TF
    Schweiz Rundsch Med Prax; 1993 Feb; 82(6):173-5. PubMed ID: 7679520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Upgrading to biventricular pacing for dilated cardiomyopathy following right ventricular pacing in a young patient].
    Carmo P; Nogueira G; Anjos R; Adragão P; Cavaco D; Ribeiras R; Neves JP; Martins M
    Rev Port Cardiol; 2012 Jan; 31(1):43-7. PubMed ID: 22154287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accuracy of uncorrected versus corrected QT interval for prediction of torsade de pointes associated with intravenous haloperidol.
    Tisdale JE; Kovacs R; Mi D; McCabe GP; Cariera BL; Sharma N; Rosman H
    Pharmacotherapy; 2007 Feb; 27(2):175-82. PubMed ID: 17253907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Torsade de pointes in myxedema. Report of a case and review of the literature].
    Albrecht Aguilera G; García Rubí D; Espinoza de los Monteros A; Mercado M; Islas Andrade S; Angeles Valdés J
    Arch Inst Cardiol Mex; 1996; 66(5):429-33. PubMed ID: 9103170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Torsade de pointes with sotalol overdose treated successfully with lidocaine.
    Assimes TL; Malcolm I
    Can J Cardiol; 1998 May; 14(5):753-6. PubMed ID: 9627533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Torsade de pointes in the management of atrial fibrillation].
    Urtubia Palacios A; Usieto López L; Fernández Esteban MI; Puértolas Ortega M
    Semergen; 2014; 40(1):e5-7. PubMed ID: 24468303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Azithromycin-induced torsade de pointes.
    Huang BH; Wu CH; Hsia CP; Yin Chen C
    Pacing Clin Electrophysiol; 2007 Dec; 30(12):1579-82. PubMed ID: 18070319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Torsade de pointe. Report of 18 cases.
    Chalak W; Taha A; Araoya M; Rifaat M
    J Med Liban; 1993; 41(2):62-8; discussion 68-9. PubMed ID: 8057345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Torsade de pointes.
    Bubien R
    Am J Nurs; 1999 Sep; 99(9):36-7. PubMed ID: 10489578
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug-induced torsade de pointes.
    Raehl CL; Patel AK; LeRoy M
    Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detrimental effects of cardiac resynchronization therapy on the non-responders.
    Luo XX; Fang F; Chui KL; Gan S; Ma Z; Yu CM
    Int J Cardiol; 2015 Oct; 197():203-5. PubMed ID: 26142207
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of epicardial or biventricular pacing to prolong QT interval and increase transmural dispersion of repolarization.
    Butter C; Schlegl M
    Circulation; 2003 Jul; 108(4):e27-8; author reply e27-8. PubMed ID: 12886940
    [No Abstract]   [Full Text] [Related]  

  • 40. Monotherapy versus combination therapy with class III antiarrhythmic agents to attenuate transmural dispersion of repolarization: a potential risk factor for torsade de pointes.
    Shah SA; Kluger J; White CM
    Pharmacotherapy; 2007 Sep; 27(9):1297-305. PubMed ID: 17723083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.